Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




First Fully Immersive 3D Augmented Reality Surgical Navigation System for Precision Spine Surgery

By HospiMedica International staff writers
Posted on 16 Jun 2022

Most surgeries are performed without navigation due to the impediments of cost and setup time. More...

Now, an augmented reality surgical navigation system that has received FDA 510(k) approval for precision guided intraoperative spine surgery marks a big step towards making precision surgical guidance widely available and economically feasible.

VisAR, an augmented reality surgical navigation system from Novarad Corporation (Provo, UT, USA), transforms a patient's imaging data into a 3-dimensional hologram which is visible through an optical visor and superimposed onto the patient with submillimeter accuracy. This allows the surgeon to focus directly on the surgical objective without looking away at a separate monitor. Novarad has partnered with Microsoft (Redmond, WA, USA) to utilize off-the-shelf augmented reality headset technology which allows for lowered cost and the ability to leverage expected hardware advancements.

VisAR is an end-to-end solution with pre-surgical planning, virtual annotations, segmentation and bi-directional image connectivity. It features integrated 2D and 3D immersive navigation views with continuous hologram-to-patient registration. VisAR technology utilizes image visible CT fiducial markers for automatic registration. The operating room setup time is less than two minutes. Surgical accuracy is sub 2 mm for pedicle screw placement in both open and minimally invasive surgical (MIS) procedures.

The untethered wirelessly connected Microsoft HoloLens 2 visor worn by the physician results in the smallest OR footprint of any system on the market. No other navigation equipment is required. VisAR is built on the Novarad imaging technology solution stack that provides interoperability, HIPAA compliance, image management, and deep security. VisAR is currently available in the US, with usage being anticipated in other countries in the coming months.

"This is transformational technology that provides the precision of a robot, the portability of a stethoscope and the versatility of human powered intelligence," said Dr. Wendell Gibby, Novarad CEO and co-creator of VisAR. "Like a surgical GPS, VisAR provides a roadmap to guide the surgeon to the pathology of interest."

"My first impression of the technology, when you actually got to put it on and see real patient images come up was, 'this is amazing. This is groundbreaking, revolutionary technology.' It's hard to explain," added Michael Karsy, MD PHD, neurosurgeon from the University of Utah.

Related Links:
Novarad Corporation
Microsoft 






Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.